By
Carlyle, Signet & OrbiMed part exit Claris Lifesciences

Private equity investors Carlyle, Signet Healthcare and OrbiMed Advisors have partially exited their investment in pharmaceutical firm Claris Lifesciences participating in the company’s buyback ...

TO READ THE FULL STORY


Leave Your Comment(s)